Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Leukemia Research|June 18, 2010
Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemiaDae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, et al.
Leukemia Research|March 16, 2018
Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemiaEun-Ji Choi, Je-Hwan Lee, Jung-Hee Lee, et al.
Leukemia & Lymphoma|December 13, 2025
Telomere length as a prognostic biomarker in myelodysplastic syndrome treated with hypomethylating agentsHyunkyung Park, Yunsuk Choi, Eun-Ji Choi, et al.
Leukemia & Lymphoma|October 10, 2025
Optimal conditioning intensity: favorable outcome of a 3-day busulfan based regimen in younger acute myeloid leukemia patientsHyunkyung Park, Je-Hwan Lee, Jung-Hee Lee, et al.
Annals of Hematology|December 8, 2011
Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factorsHan-Seung Park, Dae-Young Kim, Je-Hwan Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 15, 2014
Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation studyInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 30, 2017
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in RemissionKyoo-Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2016
Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute LeukemiaInpyo Choi, Suk Ran Yoon, Soo-Yeon Park, et al.
American Journal of Hematology|April 28, 2011
Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donorsKyoo-Hyung Lee, Seong-Jun Choi, Je-Hwan Lee, et al.
Leukemia|March 18, 2023
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trialKyoo-Hyung Lee, Suk Ran Yoon, Jeong-Ryeol Gong, et al.
Pageof 6